the attending physician 's assessment of efficacy indicated an excellent or moderate response in 89.3 % of osteoarthritis patients and 84.7 % of rheumatoid arthritis patients , with 71.2 % of the former and 51.9 % of the latter patients preferring piroxicam to the medication which was taken prior to the onset of the study .
C0003873
rheumatoid arthritis
C0031990
piroxicam